Morgan Sheng leads research and drug discovery efforts for diseases of the nervous system at Genentech. In an interview with Neuron, Dr. Sheng shares a striking moment from his postdoc training, his guiding philosophy as a scientist, and his excitement for how recent technological advances will transform neuroscience research.
Morgan Sheng is Vice-President of Neuroscience at Genentech, a leading biotech company, where he leads research and drug discovery efforts for serious diseases of the nervous system. Prior to joining Genentech (Neuron 31, 115-130; July, 2001) , which showed the importance of Shank in the regulation of dendritic spine morphology and synaptic strength-and presented it in a visually beautiful way. Two movies I particularly admire are 2001: A Space Odyssey and The Godfather.
What future direction in neuroscience are you most excited about? Most of the important mechanistic insights into neuroscience-whether from pharmacologic, electrophysiologic, molecular-cellular, or genetic approacheshave come in the past from animal models and ex vivo preparations from animal models. How the human brain works, or how the human nervous system goes wrong in disease, has been hard to get at, in large part because of the relative inaccessibility of the brain. I think the confluence of multiple technological advances of recent years-most notably, functional imaging and PET imaging of the living brain; genomics approaches such as dense genotyping, wholegenome sequencing, and RNA-seq; plus increasingly detailed phenotyping of individuals in both health and disease states-will open up more and more the neuroscience of human beings. And this will profoundly change the way we think about diseases of the nervous system-especially neuropsychiatric disorders, which currently lack a biologybased nosology. The amount of data that can be collected nowadays about human behavior and human nervous system function in physiological and pathological conditions (for instance, measurement of sleep, motor function, mood state, social interaction-all via smartphone apps) is amazing! The analysis and correlation of such data can be very informative for science, medicine, and society if done in a responsible and rigorous way. I am not a data science expert, but my current research depends more and more on computational analysis. And perhaps because I live near Silicon Valley, I sense that AI/machine learning is going to transform the way we do neuroscience research.
Which aspect of science, your field or in general, would you wish the general public knew more about? I wish the public knew more about the complexity of science, and how conclusions reached in research are often wrong or misguided. I wish the general population understood more about statistics and probability-which is a tall order as even scientists themselves don't always fully grasp these concepts. One experimental result is not necessarily definitive,
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Genentech and there are often conflicting results out there. Another gap in general knowledge is the difference between association and causality-for instance, if a high education level is associated with reduced risk of Alzheimer's disease, it does not necessarily mean staying in school will protect you from Alzheimer's.
What is your guiding philosophy for running your lab? Your personal philosophy? It sounds cliché , but my guiding philosophy is to try and tackle the most important questions in my field, exploiting new or untapped approaches if possible. Important questions are not only interesting in the intellectual sense to practicing scientists, but also impactful in the material sense to the rest of the world. Perhaps the most difficult thing in research is to carve up the important biological questions into smaller components that can be plausibly solved by one person or one group, and then identify an incisive (and perhaps novel) technology that can be applied to it.
For me it is intellectually appealing to tackle a variety of questions at any one time, so I tend to have people in the lab pursue multiple different projects that have minimal overlap (there is never any direct competition within the lab). As you can tell from my career history, I have not been shy to change the directions of research in my lab over time-from ion channel cell biology, to the postsynaptic density and synaptic plasticity, to mechanisms of neurodegenerative disease, with additional digressions along the way. Some folks might view this way of running a lab as lacking in focus-and perhaps less impactful on any one scientific area-but that's the road I have followed. It certainly keeps you learning new things and that's always stimulating! What are the questions that inspire your lab? Current questions are: what are the molecular and cellular mechanisms underlying neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and ALS? Is there any disease pathogenesis pathway that can be therapeutically targeted to benefit patients with these diseases? I also believe that there is significant mechanistic overlap between neurodegenerative and neuropsychiatric disorders, so what we learn in one area can be helpful to the other. Do you have a favorite anecdote from doing science that you'd like to share (perhaps a key discovery moment)? It's great when you can take advantage of new techniques to address interesting questions. During my postdoc, I noted that certain ion channels and receptors have specific, and sharply different, subcellular locations on the surface of neurons. A simple hypothesis was that they bound to different cytoplasmic anchoring proteins. How to identify those interacting proteins? Another postdoc in the Jan lab (Cheng-ting Chien, now at Academia Sinica, Taiwan) taught me how to screen for interacting proteins using the yeast two-hybrid system (an emerging technique at the time). The inventive step we took was to use just the cytoplasmic tail of the ion channel or receptor as ''bait.'' Through those ''fishing'' experiments, I discovered PSD-95 family proteins as binding partners of NMDA receptors and certain K+ channels, which led to the identification of PDZ domains as binding modules for C-terminal motifs, and which culminated in the concept that the postsynaptic density is built around PDZ domain-containing scaffold proteins. Of course, all this was future fantasy when I sequenced the first positive hits in the yeast two-hybrid screen. When the sequence turned up as being similar to Discs large (the Drosophila homolog of PSD-95), I asked ''What's Discs large''? and Cheng-ting Chien replied, ''I don't know, but it might make you famous.'' In a related anecdote: I was deep into sequence gazing around that time, and while scanning the NMDA receptor genes, I almost fell off my chair when I saw my family name ''-S-H-E-N-G-'' spelled out in the single letter code sequence of NMDA receptor subunit GluN1, not far from the cytoplasmic tail. Now, if that is not a divine signal to go into synaptic plasticity research, then what is?
What has been the highlight of your career? I have been lucky throughout my career to be in many right places at the right times. It's hard to pick out one single event or one specific achievement. Rather I have to say that the highlight has been the steady stream of sharp minds and stimulating personalities I have had the good fortune to work with in my lab. The list of individuals is too long to name, but many of them have become accomplished and well known in their own right. Proverbially speaking, if I should be contemplating my career on my deathbed, I will be remembering those coworkers I became friends with, rather than any scientific highlight.
Who were your key early influences? I had an inspirational teacher during my teen years (Mr. Carlton) who made chemistry absorbing and fun. My PhD advisor, Mike Greenberg, impressed me with his scientific smarts and engaged me with his drive and warmth. Lily Jan, my postdoc advisor, was unmatched in her scholarship and showed exceptional scientific generosity and humility. I learned much about how to be a good scientist and a decent person from those individuals.
What motivated you to become a scientist? I don't think I ever chose to be a scientist. I kind of wandered into science and then found myself well suited to it. What motivates me to stay in science is that, as a profession, it is intellectually stimulating, full of smart and interesting (mostly nice) people, and you usually don't have to answer to any boss.
What is your view on big datagathering collaborations as opposed to hypothesis-driven research by small groups? I am not sure I agree with the tone of the question that big data is gathered only by collaborations, whereas hypothesisdriven research is done by small groups. These days, even individuals can easily generate large datasets if equipped with the right resources (e.g., single-cell RNA-seq). Often the novel advances in the field come from a juxtaposition of large datasets and hypothesis-driven research. I do believe that data-intensive science is becoming more and more important in neuroscience-for example, human genetics, gene expression/proteomic profiling, brain imaging, multielectrode recording, connectomics, and complex behavioral analysis, all of which involve measurements of many variables in many samples. Although formulating and testing hypotheses is a critical part of science, I think that the non-hypothesis-driven (i.e., purely observational) approach is often underrated. The trouble is that practicing scientists tend to try to prove their hypotheses rather than to disprove them; in the present culture, the rewards for positive results are so much greater than for negative results. Personally, I am more likely to believe the data and conclusions from non-hypothesis-driven research, and I encourage my own trainees to initiate new projects based on novel discoveries from non-hypothesis-driven experiments. After all, some of the most significant advances in neuroscience stemmed from careful observation without the conceit of hypothesis (e.g., Hubel and Wiesel's ocular dominance and orientation columns, forward genetics of neurodevelopmental or behavioral mutants in fly and worm).
What do you think are the biggest problems/challenge science as a whole is facing today? Just as with the ''wealth gap'' in society at large, I feel that there is a widening inequality among academic scientists. The rich tend to get richer, while the rest struggle to keep their labs running. There is huge pressure to be first, because coming second means you are ''scooped''-of top-flight publication, glory, and even funding. This winner-takes-all culture leads to cutting corners on scientific rigorousness and deflation of spirit among young scientists, who cannot all be winners. Another (perhaps related) problem facing science is the high rate of nonreproducibility of high-profile publications. There are many reasons for this, which have been much discussed, but I feel one of the most important is experimenter bias. We have to do a better job in training students to do experiments in a blinded fashion and to be masters (not slaves) of statistics. How do you view the level of crosstalk between disciplines, (for ex., physics, mathematics, engineering, humanities, and social science)? In a big biotech company, like the one I work for, the level of interaction between different disciplines (engineering, physics, computer science, clinical, biostatistics, regulatory, finance, business development, etc.) is plentiful and productive. People are always motivated to collaborate when they have a common goal and are organized in teams to achieve that goal.
What advice do you find yourself giving to your students and postdocs? Do research that directly confronts an important question. Take a step back from the data details and think in fundamental terms when formulating the question and articulating the conclusion. Try to design experiments in such a way that either a negative or positive result carries meaning. Don't believe everything you read in the literature (but on the other hand, even weak papers have some truth in them).
How do you find inspiration?
Looking at exciting new data that no one else has ever seen before (well, no one outside of the lab at least); attending seminars far outside of my field (e.g., anthropology, economics, and conservationism) given by eloquent speakers who are passionate about their subject; and meeting real people (patients and their caregivers) who suffer from the disease that you profess to do research on.
What question keeps you awake at night? I have no problems sleeping when I want to. If there is anything that keeps me up at night it is watching TV-there are just too many great shows and too many sports games to watch.
What do you do when you're not in the lab? When I am not working, I like to go to the gym and work out while listening to news and other podcasts. I also try to do regular yoga and play occasional sports with my kids. Cooking and eating with my ''foodie'' family is a particularly enjoyable activity. Traveling is a major reason for being out of the lab, but it is not as fun as it used to be earlier in my career.
Did you encounter particular difficulties? How did you overcome them? Probably the biggest challenge of my career was work-life balance (or rather, lack of it). Looking back, I feel that I erred on the side of working too hard. I wish I had spent a bit more time with my kids when they were growing up.
What career paths did you consider other than a scientist? Not only did I consider non-scientist career paths, I actually took them! My first job was junior medical doctor (internal medicine); I have never been more work stressed in my career since. Then I went into academia doing basic science research, which I found I was better at. Most recently I joined industry as a vicepresident of a large biotech company, which is an interesting combination of science and management and entrepreneurship. With all that said, my dream job would have been film director, because it epitomizes creativity within a multidisciplinary team and has potential to reach a wide audience (more than the readership of Neuron!).
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